… from the Surveillance, Epidemiology, and End Results (SEER… to compare survival outcomes
between patients grouped by … as a specific presentation of many other myeloid neoplasms, …

… The reported epidemiology of MS varies greatly but typically presents … distinguish between
isolated MS and MS presenting with synchronous BM involvement by AML. We know isolated …

… with MS with <20% BM blasts and suggests that monitoring … marrow blasts, presentation with
an isolated solid mass or skin … at the time of their presentation to our institution. Details of the …

… In the present study, only one of our patients presented erythroblastic MS, but none of the …
. Isolated meningeal chloroma (granulocytic sarcoma) in a child with acute lymphoblastic …

… Figure 1 Clinical presentations of myeloid sarcoma … In addition, while monitoring treatment
outcomes, PET-CT may … treatment outcomes of pediatric patients with isolated MS versus …

… 472 patients: 244 patients with isolated myeloid sarcoma (… This study collected data from
patients aged 15 years and older … time of presentation, MS was classified into isolated myeloid …

… for patients with isolated (low patient number, … the outcome of allogeneic HSCT has been
documented in a large study including 310 centers from 44 countries [125]. No impact between …

… About 75–90% of patients with isolated eAML will develop … to difficulty in accurately defining
its epidemiology. Complicating the … patients implicates an escape from immune surveillance, …

… Clinical presentation of myeloid sarcomas can be highly variable based on the tumor site,
size… of isolated pancreatic MS several years post-stem cell transplant in a nonleukemic patient. …

… , localization, and monitoring of response to treatment. PET/… between isolated myeloid sarcoma
and myeloid sarcoma with … disease at presentation (including myeloid sarcoma, leukemia …